1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Current treatment and recent progress in gastric cancer
    Review

    Joshi, S. S.; Badgwell, B. D.
    CA - A Cancer Journal for Clinicians (2021)

    Fulltext@MSK | Save
  • Preoperative CT predictors of survival in patients with pancreatic ductal adenocarcinoma undergoing curative intent surgery
    Journal Article

    Dickinson, S. M.; McIntyre, C. A.; Schilsky, J. B.; Harrington, K. A.; Gerst, S. R.; Flynn, J. R.; Gonen, M.; Capanu, M.; Wong, W.; Lawrence, S.; more...
    Abdominal Radiology (2021)

    Fulltext@MSK | Save
  • Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): An open-label, randomised, phase 3 trial
    Journal Article

    Andre, T.; Amonkar, M.; Norquist, J. M.; Shiu, K. K.; Kim, T. W.; Jensen, B. V.; Jensen, L. H.; Punt, C. J. A.; Smith, D.; Garcia-Carbonero, R.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • KRAS(G12C) mutation is associated with increased risk of recurrence in surgically resected lung adenocarcinoma
    Journal Article

    Jones, G. D.; Caso, R.; Tan, K. S.; Mastrogiacomo, B.; Sanchez-Vega, F.; Liu, Y.; Connolly, J. G.; Murciano-Goroff, Y. R.; Bott, M. J.; Adusumilli, P. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Phase 2 study of zenocutuzumab (MCLA-128), a bispecific HER2/HER3 antibody in NRG1 fusion-positive advanced solid tumors
    Meeting Abstract

    Schram, A.; Macarulla, T.; O'Reilly, E.; Rodon, J.; Wolpin, B.; Ou, S.; Kim, D.; Yang, J. C.; Lam, J.; De Langen, A.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Does post-operative radiotherapy and chemotherapy in older adults with head and neck cancer correlate with frailty?
    Meeting Abstract

    Restifo, D.; Raab, G. T.; Tin, A.; Shahrokni, A.; Zakeri, K.
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Outcomes following head and neck cancer surgery among fit and frail older adults as determined by an electronic geriatric assessment
    Meeting Abstract

    Raab, G. T.; Restifo, D.; Tin, A.; Shahrokni, A.; Zakeri, K.
    Journal of the American Geriatrics Society (2021)

    Fulltext@MSK | Save
  • Longitudinal evaluation of quality of life (QoL) in patients (Pts) with FGFR2-driven cholangiocarcinoma (CCA) treated with pemigatinib
    Meeting Abstract

    Valle, J. W.; Bibeau, K.; Cho, Y.; Ren, H.; Feliz, L.; Lihou, C. F.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Final results from ClarIDHy, a global, phase III, randomized, double-blind study of ivosidenib (IVO) versus placebo (PBO) in patients (pts) with previously treated cholangiocarcinoma (CCA) and an isocitrate dehydrogenase 1 (IDH1) mutation
    Meeting Abstract

    Zhu, A. X.; Macarulla, T.; Javle, M. M.; Kelley, R. K.; Lubner, S. J.; Adeva, J.; Cleary, J. M.; Catenacci, D. V. T.; Borad, M. J.; Bridgewater, J. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Population-based, real-world prognostic factors related to survival among patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)
    Meeting Abstract

    Yu, K. H.; Cockrum, P.; Surinach, A.; Wang, S.; Chu, B. C.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save